Amundi Asset Management US’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$679K Buy
2020
Q4
$842K Hold
2020
Q3
$460K Hold
2020
Q2
$404K Hold
2020
Q1
$233K Hold
2019
Q4
$335K Hold
2019
Q3
$225K Buy
2019
Q2
$203K Hold
2019
Q1
$154K Sell
2018
Q4
$126 Buy
2018
Q3
$142K Hold
2018
Q2
$188K Buy
2018
Q1
$128K Sell
2017
Q4
$75K Buy